Laddar...
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)
OBJECTIVE: It is well established that higher low-density lipoprotein (LDL)-cholesterol levels are associated with increased cardiovascular risk. We analyzed whether effects of empagliflozin on cardiovascular outcomes varied by different LDL-cholesterol levels at baseline in EMPA-REG OUTCOME. METHOD...
Sparad:
| I publikationen: | Diab Vasc Dis Res |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publications
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7919220/ https://ncbi.nlm.nih.gov/pubmed/33307785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164120975256 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|